Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and

Andrew R Harper1,2, Anuj Goel1,2, Christopher Grace1,2

  • 1Radcliffe Department of Medicine, Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.

Nature Genetics
|January 26, 2021
PubMed

Insights

Genetic factors significantly influence hypertrophic cardiomyopathy (HCM), a serious heart condition. Common genetic variants and modifiable risk factors like blood pressure play key roles in HCM development and severity.

Area of Science:

  • Cardiovascular Genetics
  • Genomics
  • Heart Disease Research

Background:

  • Hypertrophic cardiomyopathy (HCM) is a common yet serious genetic heart disorder.
  • Existing research links rare sarcomere gene variants to HCM, but this doesn't explain the full picture of phenotypic heterogeneity or cases lacking these variants.

Purpose of the Study:

  • To investigate the genetic architecture of HCM beyond rare sarcomere variants.
  • To identify common genetic variants and modifiable risk factors contributing to HCM.
  • To explore the clinical actionability of genetic insights and risk factors in HCM.

Main Methods:

  • Conducted a genome-wide association study (GWAS) involving 2,780 HCM cases and 47,486 controls.
  • Calculated single-nucleotide polymorphism (SNP) heritability to assess polygenic influence, particularly in sarcomere-negative HCM.
  • Developed and validated a genetic risk score (GRS) for HCM and used Mendelian randomization to identify modifiable risk factors.

Main Results:

  • Identified 12 novel genome-wide-significant loci associated with HCM susceptibility.
  • Demonstrated a strong polygenic influence on HCM, especially in sarcomere-negative cases (h²g = 0.34 ± 0.02).
  • A GRS significantly impacted HCM odds and phenotypic severity; Mendelian randomization linked diastolic blood pressure (DBP) to a fourfold increased HCM risk in sarcomere-negative cases.

Conclusions:

  • Common genetic variants play a substantial role in HCM pathogenesis, contributing to phenotypic heterogeneity.
  • Modifiable risk factors, notably diastolic blood pressure, are crucial for sarcomere-negative HCM and present actionable targets.
  • These findings suggest a paradigm shift towards integrating polygenic risk and modifiable factors for clinical management of HCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
148
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
669
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
213
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
124
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.1K